Risk factors for development of de novo neoplasia after liver transplantation

被引:79
作者
Xiol, X
Guardiola, J
Menendez, S
Lama, C
Figueras, J
Marcoval, J
Serrano, T
Botargues, JM
Mañner, M
Rota, R
机构
[1] Hosp Bellvitge Princeps Espanya, Dept Gastroenterol, Lhospitalet De Llobregat 08907, Barcelona, Spain
[2] Hosp Bellvitge Princeps Espanya, Dept Gen Surg, Lhospitalet De Llobregat 08907, Barcelona, Spain
[3] Hosp Bellvitge Princeps Espanya, Dept Pathol, Lhospitalet De Llobregat 08907, Barcelona, Spain
[4] Hosp Bellvitge Princeps Espanya, Dermatol Unit, Lhospitalet De Llobregat 08907, Barcelona, Spain
[5] Hosp LAlt Penedes, Gastroenterol Unit, Barcelona, Spain
关键词
D O I
10.1053/jlts.2001.28744
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplant recipients are at greater risk for de novo neoplasia, especially lymphoma and nonmelanoma skin cancer; however, risk factors for this complication have not been well studied. Clinical and pathological records of 137 consecutive liver transplant recipients who had survived for at least 1 year were reviewed to register de novo neoplasia. Ten variables were analyzed for their association with the development of de novo malignancies by means of a log-rank test and stepwise selection in a multivariate analysis using the Cox proportional hazard model. Thirty de novo neoplasias appeared in 22 of 137 transplant recipients between 12 and 104 months after orthotopic liver transplantation (OLT; median follow-up, 69 months): 14 patients had 21 skin cancers, 6 patients had solid-organ cancer, and 3 patients developed a lymphoproliferative disease. Probabilities of de novo neoplasia were 13% at 5 years post-OLT and 26% at 8 years post-OLT. The only associated risk factor for any neoplasia was age. Age and hepatocarcinoma were independent risk factors associated with skin cancer. That hepatocarcinoma in the explanted liver is an independent risk factor for skin cancer suggests there is individual susceptibility to both neoplasias.
引用
收藏
页码:971 / 975
页数:5
相关论文
共 33 条
[21]  
2-8
[22]   p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status [J].
McGregor, JM ;
Berkhout, RJM ;
Rozycka, M ;
terSchegget, J ;
Bavinck, JNB ;
Brooks, L ;
Crook, T .
ONCOGENE, 1997, 15 (14) :1737-1740
[23]   Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma [J].
Muto, Y ;
Moriwaki, H ;
Ninomiya, M ;
Adachi, S ;
Saito, A ;
Takasaki, KT ;
Tanaka, T ;
Tsurumi, K ;
Okuno, M ;
Tomita, E ;
Nakamura, T ;
Kojima, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) :1561-1567
[24]   Skin cancer in Australian heart transplant recipients [J].
Ong, CS ;
Keogh, AM ;
Kossard, S ;
Macdonald, PS ;
Spratt, PM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 40 (01) :27-34
[25]   Skin cancer in liver transplant recipients [J].
Otley, CC ;
Pittelkow, MR .
LIVER TRANSPLANTATION, 2000, 6 (03) :253-262
[26]  
Penn I, 1996, Liver Transpl Surg, V2, P109
[27]   NONMELANOMA CANCERS OF THE SKIN [J].
PRESTON, DS ;
STERN, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (23) :1649-1662
[28]   Hepatocellular carcinoma [J].
Schafer, DF ;
Sorrell, MF .
LANCET, 1999, 353 (9160) :1253-1257
[29]   MALIGNANCIES AFTER LIVER-TRANSPLANTATION - A COMPARATIVE REVIEW [J].
TANSHALABY, J ;
TEMPERO, M .
SEMINARS IN LIVER DISEASE, 1995, 15 (02) :156-164
[30]  
Wassberg C, 1999, INT J CANCER, V80, P511, DOI 10.1002/(SICI)1097-0215(19990209)80:4<511::AID-IJC5>3.0.CO